课题基金 / 基金详情

Molecular Physiology of Neuromusclar Diseases

Molecular Physiology of Neuromusclar Diseases
神经肌肉疾病的分子生理学
批准号:
6868107
负责人:
STEPHEN C. CANNON
金额:
$34.05万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-03-10 至 2008-03-31

项目摘要

项目成果

STEPHEN C. CANNON的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请方提供):肌强直和周期性麻痹是骨骼肌的遗传性疾病,其中电压门控离子通道突变改变了肌膜的电兴奋性。该项目的长期目标是表征突变通道的功能缺陷,并确定异常通道行为如何产生症状。对于这些疾病,肌肉功能障碍是由电兴奋性的间歇性紊乱引起的,这可能是病理性增强或抑制。肌强直是一种兴奋性增强的疾病,其中单一刺激激发动作电位的爆发,产生持续数秒的非自主持续肌肉收缩。相反,周期性麻痹是由去极化引起的肌肉兴奋性丧失引起的。氯离子通道突变引起肌强直,而钾或钙通道突变引起周期性麻痹。骨骼肌钠通道(由SCN 4A编码的NaV1.4)中的错义突变可能导致肌强直、周期性麻痹或同一个体中的两者。这种临床表型变异的病理生理学基础,都是由共同钠通道基因突变引起的,是本提案研究的主要焦点。我们的实验方法是通过测量离子电流来识别突变通道行为的改变,然后使用计算机或动物模型来探索通道功能的特定改变如何导致肌强直或周期性麻痹。目的1是确定额外的功能缺陷,尚未表征,NaV1.4突变体,从而进一步定义门控缺陷,引起特定形式的改变膜兴奋性的生物物理概况。我们和其他人之前的工作已经确定了慢失活门控是易感性弱点攻击的关键决定因素。与其他门控转换相比,对慢失活的了解相对较少。目的2旨在提高我们的理解缓慢失活,通过精细的电压依赖性门控协议和半胱氨酸扫描诱变的基础上的结构研究相结合。目的3探讨如何在Na通道行为的功能缺陷导致肌强直或周期性麻痹,通过表征小鼠模型与NAY 1.4中的靶向突变,并使用基于计算机的肌肉兴奋性模型。已知超过30种人类疾病是由电压门控离子通道突变引起的。拟议的研究旨在为一组人类通道病的病理生理基础提供更完整的理解:从基因缺陷到临床症状。这些研究也将进一步我们的知识钠通道功能在分子水平上,将导致一个更好的理解肌肉兴奋性的决定因素,将提供一个更合理的设计治疗策略的机制的见解,并将作为一个模型系统,了解更常见的兴奋性疾病,如癫痫或心律失常。
英文摘要
DESCRIPTION (provided by applicant): The myotonias and periodic paralyses are heritable diseases of skeletal muscle in which mutations of voltage-gated ion channels alter the electrical excitability of the sarcolemma. The long-term goals of this project are to characterize the functional defects of mutant channels and to determine how abnormal channel behavior produces symptoms. For these disorders, muscle dysfunction is caused by intermittent derangements in electrical excitability, which may be pathologically enhanced or depressed. Myotonia is a disorder of enhanced excitability wherein a single stimulus elicits a burst of action potentials that produces involuntary persistent muscle contraction lasting seconds. Conversely, periodic paralysis results from a depolarization-induced loss of muscle excitability. Chloride channel mutations cause myotonia, whereas mutations in potassium or calcium channels give rise to periodic paralysis. Missense mutations in a skeletal muscle sodium channel (NaV1.4 encoded by SCN4A) may cause myotonia, periodic paralysis, or of both in the same individual. The pathophysiological basis for this variation in clinical phenotype, all arising from mutations in a common sodium channel gene, is a major focus of the studies in this proposal. Our experimental approach is to identify alterations in the behavior of mutant channels by measuring ionic current, and then use computer or animal-based models to explore how specific alterations in channel function cause myotonia or periodic paralysis. Aim 1 is to identify the functional defects for additional, as-yet uncharacterized, NaV1.4 mutants and thereby define further the biophysical profile of gating defects that give rise to specific forms of altered membrane excitability. Prior work, by us, and others, has identified slow-inactivation gating as a critical determinant in the predisposition to attacks of weakness. In comparison to other gating transitions, relatively little is known about slow inactivation. Aim 2 seeks to improve our understanding of slow inactivation through a combination of refined voltage-dependent gating protocols and structural studies based on cysteine-scanning mutagenesis. Aim 3 explores how functional defects in Na channel behavior cause myotonia or periodic paralysis by characterizing a mouse model with a targeted mutation in NAY1.4 and using computer-based models of muscle excitability. More than 30 human disorders are known to be caused by mutations in voltage-gated ion channels. The proposed studies are designed to provide a more complete understanding of the pathophysiological basis for a group of human channelopathies: from gene defect to clinical symptoms. These studies will also further our knowledge of Na channel function at the molecular level, will lead to an improved understanding of the determinants of muscle excitability, will provide mechanistic insights for a more rational design of therapeutic strategies, and will serve as a model system for understanding more common disorders of excitability such as epilepsy or cardiac arrhythmia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathophysiology of Myotonia and Periodic Paralysis
Pathophysiology of Myotonia and Periodic Paralysis
Pathophysiology of Myotonia and Periodic Paralysis
Disease Pathogenesis and Modification for CaV1.1-Associated Hypokalemic Periodic
海外基金